Pharma

obesity overweight weight loss weigh
Pharma

England's NICE to phase rollout for Lilly's tirzepatide in obesity

Roughly 220,000 people in England will be eligible for the drug during the three-year launch phase.
Zoey Becker Dec 4, 2024 7:01pm
Go sign green light

Merus' Bizengri wins FDA nod as 1st drug to target NRG1+ cancers

Dec 4, 2024 6:55pm
KnippeRx Transforms Patient Assistance Programs through Technology and Patient-Focused Solutions

KnippeRx Transforms Patient Assistance Programs through Technology and Patient-Focused Solutions.

Dec 2, 2024 8:00am
Novo Nordisk

Novo unveils plans for $400M quality control hub in Denmark

Dec 4, 2024 2:53pm
video
Mastering Omnichannel Pharma Marketing Integrating CTV OTT and Traditional Media

Mastering Omnichannel Pharma Marketing: Integrating CTV, OTT, and Traditional Media

Oct 14, 2024 8:00am
China

AZ's Enhertu, Akeso's bispecifics win reimbursement in China

Dec 4, 2024 12:52pm